Brad Wouters 🇨🇦

Scientists @PMResearch_UHN led by @Schwartastic have developed CellNEST, a powerful AI tool that maps how cells talk to each other. By detecting complex signals between cells, it could lead to new ways to target tumours and stop disease progression. 🔗uhnresearch.ca/news/pinpointi…

We are proud to share a remarkable outcome at Roswell Park Comprehensive Cancer Center: 100% of patients who underwent allogeneic transplant in 2024 reached six-month survival. I never thought we would ever see such a statistic in our field. roswellpark.org/newsroom/20250…

Congrats @Homaira_H for winning best poster at #bcvs2025 @AHAScience. You do @UHN_Research @PMunkCardiacCtr @TBEP_UofT @trogersresearch @CIHR_IRSC proud!

Seeing @ldawsonmd present data highlighting the important role of RT ☢️ in HCC management is always a treat! Does your pt have HCC w/ MVI? Consider SBRT per RTOG 1112! Dose doesn’t even need to be that high 😉 (Avg ~35 Gy / 5 Fx) @NRGonc @RTOGFoundation

🚨🚨🚨 We are activating this single-arm phase 2 trial of hypofractionated RT to oligoprogressive metastatic #melanoma, up to 10 lesions + extensive specimen collection for correlatives. There's an unmet need in this area - hope results of the trial will benefit more patients.

Our Collaborative Centre for Clinical Research is leading the IA45 initiative with a goal that all clinical research studies can be activated in 45 days. Good for patients, good for research progress.

👋👋👋Special shoutout to @UHN @UHN_Research THE PROTOCOL WAS ACTIVATED WITHIN 45 DAYS OF SUBMISSION, per the new IA45 pathway. The extreme dedication/efficiency of the whole team is unparalleled.

finish something.

In a study published in @NatureCancer, Dr. John Dick at UHN's @pmcancercentre and team investigated the ability of cells to change from one type to another in B-cell acute lymphoblastic leukemia, and how it affects treatment response. Read more: bit.ly/4lNeAZv

The R01 Grant pay-line is at the 4th %-ile at @theNCI (4 out of 100 reviewed grants will be awarded this year) “expect to fund through the 4th percentile for those EI/NI applications” Funding Policy NCI Full Year Funding Policy for RPG Awards FY 2025 cancer.gov/grants-trainin…

Are you a recent/soon-to-be PhD graduate in immunology or a related field? Want to develop novel therapeutics for lung disease/lung transplantation? We are looking for postdoctoral fellow through the the UHN Canada Leads opportunity uhn.ca/corporate/Abou…. Please get in touch!

🗓️ DEADLINE | Only 4 weeks left! Submit your Notice of Intent to Apply for the #NFRF 2025 Exploration competition by August 19. Get the details: sshrc-crsh.gc.ca/funding-financ…

The rise in lung cancer in nonsmokers and colorectal cancer in young people should alarm all of us. Glad to see this getting mainstream attention: nytimes.com/2025/07/22/wel… Less discussed but very real is the rise in #CCA and young females with adenoma--> #HCC

China has taken a commanding lead in the exploding field of #AI research, despite U.S. restrictions on exporting key computing chips to its rival, finds a new report. scim.ag/3GTaU9l @NewsfromScience

Here Tony Lam and colleagues @UHN identify that lipid sensing in HFD-fed rats is enhanced by metformin to trigger an endocrine GIP to NTS GIPR axis to reduce food intake unveiling potential targets to enhance GIP action and reduce weight in #obesity diabetesjournals.org/diabetes/artic…

Thrilled to share that we placed 1st in the 2025 MEDIQA Clinical NLP Challenge — marking our third consecutive win (2023, 2024, 2025)! 🏆🎉 This year’s task went beyond clinical note generation — it focused on extracting structured medical orders from noisy, free-form…

We're hiring an MLOps Engineer! Join us in transforming healthcare with AI. Tackle complex health system challenges, make a real-world impact, and drive innovation. 🔗Apply now: jobs.smartrecruiters.com/UniversityHeal…

The distribution and combination of inflammatory cells are associated with the HLA haplotype/allele an individual with PSP carries. This opens a novel conceptual approach in the interpretation of inflammatory responses in Neurodegenerative diseases: medrxiv.org/content/10.110…

The rise of China’s pharmaceutical industry from 2015–2024 nature.com/articles/d4157… This new article analyses the growth in drug innovation in China, the underlying environmental factors and strategic trends such as the outlicensing of assets originating in Chinese companies

The mantra “location, location, location” isn’t just about real estate. For life scientists, more than 50% of their productivity can be attributed to the institution where they work, according to a new study. @ScienceCareers scim.ag/44V9Vxo